Learn the 5 Strategies to Scale Outcomes and ROI to Rising-Risk Populations During and After the Pandemic
COVID-19 has hit provider organizations hard with challenges including: lost revenue, reduced staff, and uncontrolled chronic conditions while the most critical patients avoid care. Population health leaders, especially those in value-based contracts, face a fourth challenge: rising-risk patients.
Under the status quo, providers rely on manual traditional care management and device-based technology that does not scale to reach sufficient populations. As a result, providers lack the ability to proactively reach a large and costly population- rising-risk patients, and lose timely opportunities to bend the cost curve and prevent rising-risk patients from becoming high-cost utilizers.
Simply put: It’s not enough to focus on high-risk patients alone.
Read this white paper and step through five strategies for improving clinical and financial outcomes during and Post-Pandemic, as well as real life examples of how CareSignal client-partners have successfully implemented these strategies and scaled Deviceless RPM.
CareSignal is a Deviceless Remote Patient Monitoring™ platform that improves payer and provider performance in value-based care. The company leverages real-time, self-reported patient data and artificial intelligence to produce long-term patient engagement while identifying clinically actionable moments for proactive care. Its evidence-based platform has been proven in 10 peer-reviewed studies and over a dozen payer and provider implementations across the U.S. to sustainably scale care teams to help 10 times more patients, resulting in significant improvements in chronic and behavioral health outcomes and reduced ED utilization. With confidence in its outcomes, CareSignal offers partners at-risk pricing and consistently delivers 4.5 times to 10 times ROI within the first year of its partnerships. For more information, visit our website or try a self-guided demo.